Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Sleep Aids market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Sleep Aids market in Latvia has been experiencing steady growth in recent years.
Customer preferences: Latvian consumers have shown an increasing interest in sleep aids due to various factors. One of the key reasons is the growing awareness about the importance of good sleep for overall health and well-being. As people become more health-conscious, they are actively seeking ways to improve their sleep quality, leading to a higher demand for sleep aids.
Trends in the market: One of the notable trends in the Sleep Aids market in Latvia is the shift towards natural and herbal sleep aids. Consumers are becoming more inclined towards products that are perceived as natural and organic, as they are seen as safer and have fewer side effects compared to synthetic alternatives. This trend aligns with the global shift towards natural and holistic wellness solutions, reflecting the growing interest in sustainable and healthy lifestyles. Another trend in the market is the rise of sleep tracking devices and apps. These technologies allow individuals to monitor their sleep patterns and gain insights into their sleep quality. As people become more interested in understanding and improving their sleep, the demand for sleep tracking devices and apps has increased. This trend is driven by the growing adoption of wearable technology and the increasing availability of sleep tracking features in smartphones and smartwatches.
Local special circumstances: Latvia has a high prevalence of sleep disorders, which contributes to the demand for sleep aids. Factors such as stress, long working hours, and lifestyle changes have led to an increase in sleep-related problems among the Latvian population. This has created a need for effective sleep aids that can help individuals overcome sleep difficulties and improve their quality of life.
Underlying macroeconomic factors: The growing Sleep Aids market in Latvia can also be attributed to favorable macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable incomes. As people have more purchasing power, they are more willing to invest in products and services that can improve their quality of life, including sleep aids. Furthermore, the aging population in Latvia is also driving the demand for sleep aids. As people age, they are more likely to experience sleep problems and disorders. The increasing number of elderly individuals in Latvia has created a larger market for sleep aids, as older adults seek solutions to improve their sleep and overall well-being. In conclusion, the Sleep Aids market in Latvia is growing due to increasing customer preferences for natural and herbal sleep aids, the rise of sleep tracking devices and apps, the high prevalence of sleep disorders in the country, and favorable macroeconomic factors such as steady economic growth and an aging population.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights